(Q38569589)

4 September 2017

0 references

Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis (English)

1 reference

acute decompensated heart failure

4 September 2017

1 reference

9

Hugo A Katus

1 reference

4 September 2017

Jennifer Franke

1

1 reference

4 September 2017

Dorothee Schmahl

2

1 reference

4 September 2017

Stephanie Lehrke

3

1 reference

4 September 2017

Regina Pribe

4

1 reference

4 September 2017

Raffi Bekeredjian

5

1 reference

4 September 2017

Andreas O Doesch

6

1 reference

4 September 2017

Philipp Ehlermann

7

1 reference

4 September 2017

Philipp Schnabel

8

1 reference

4 September 2017

Christian Zugck

10

1 reference

4 September 2017

27 September 2011

1 reference

4 September 2017

Case Reports in Medicine

1 reference

4 September 2017

2011

1 reference

4 September 2017

203690

1 reference

Creative Commons Attribution 3.0 Unported

4 September 2017

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180827

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180827

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180827

Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180827

[Ivabradine - a new therapeutic option for cardiogenic shock?].

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180827

Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180827

Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180827

Preservation of coronary reserve by ivabradine-induced reduction in heart rate in infarcted rats is associated with decrease in perivascular collagen

31 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21966292

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2011/203690

1 reference

4 September 2017

1 reference

4 September 2017

PubMed publication ID

21966292

1 reference